It is currently Mon Aug 31, 2015 11:03 am

News News of Tcelna (Tovaxin)

Site map of Tcelna (Tovaxin) » Forum : Tcelna (Tovaxin)

A board to discuss Tcelna as a treatment for Multiple Sclerosis

Australian Neurologists knowledge of

I saw a second neurologist here in Australia today. He is running Phase III trials for both FTY720 & BG12. I was suprised when he told me he had not herd of Tovaxin at all. This is the second neurologist in Sydney that I have seen that has not herd of it. The first is my main neurologist who, from what I understaand, is one of the most respected MS neurologists in Australia.

I really ...
Read more : Australian Neurologists knowledge of | Views : 2851 | Replies : 11


Tovaxin and Progessive MS?

Hi all,
Starting this trial path has made me wonder if anyone, in any stage of the trial has had or suspected they were in the "progressive ms" group. Were any of the initial phases open to progressive patients? What were the results etc.? I have long suspected I was in the progressive group. I have never had any remittance since my diagnosis (nearly 8 months), only slowly worsening symptoms. I have never been given ...
Read more : Tovaxin and Progessive MS? | Views : 4737 | Replies : 17


Possitve MRTC

Hi all,
Found out today that my mrtc was possitive. Apparently the Advair steriod in question made little or no difference. Maybe the bar has indeed been lowered. I have stopped Advair and swithed to Singular which seems to be working so far. I will schedule bag o' blood Monday.
Read more : Possitve MRTC | Views : 3129 | Replies : 9


dose escalation results

April 03, 2007 07:00 AM Eastern Daylight Time
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with TovaxinTM for Multiple Sclerosis
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company involved in the development and commercialization of cell therapies, today announced positive top-line data in an open-label Phase I/II dose escalation clinical trial of the investigational T-cell vaccine, Tovaxin™, for multiple sclerosis. In this one-year, 10-subject dose escalation clinical trial, ...
Read more : dose escalation results | Views : 2675 | Replies : 10


first blood work. MRTC

Hi all,
I had my initial blood work done yesterday. Standard tests, questions and so on. I wanted to put in my 2 cents on the mrtc issue. I spoke in length about it with the clinic Neuro. I have heard a lot of theories about why folks test negative. First, my clinic has had only one negative mrtc out of six and that one had a questionable diagnosis. Only one small lesion on the ...
Read more : first blood work. MRTC | Views : 13672 | Replies : 75


Opexa 2006 Year End Financial Report

Here's a link to Opexa's 2006 Financial Report which may be of interest to folks here at ThisIsMS. Note that it was released on March 19, 2007.

NHE
Read more : Opexa 2006 Year End Financial Report | Views : 1511 | Replies : 1


Extension Study for Tovaxin

I had a request to ask about the extension study after the Phase IIb for Tovaxin. I don't remember who, but someone asked if we find out about our initial trial and whether or not we were getting the goods.

Everyone in the trial gets to participate in the extension. Everyone will find out if they were getting the drug or the placebo. I think that this is important to them as well. Anyway, I ...
Read more : Extension Study for Tovaxin | Views : 2017 | Replies : 4


NEW TOVAXIN CLINICAL TRIAL SITE

I just got an alert on this and haven't even had a chance to check it out yet http://www.tovaxin.com/

Bob
Read more : NEW TOVAXIN CLINICAL TRIAL SITE | Views : 1654 | Replies : 0


Opexa related info

This isn't specific to Opexa's MS vaccine trial, but it's good to see that they're getting positive results with their other studies.
    Opexa Announces Encouraging Clinical Data on Novel T-Cell Vaccination Therapy for Rheumatoid Arthritis

    THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, announced encouraging data from a clinical trial of 15 patients with rheumatoid arthritis (RA). Published in Arthritis & Rheumatism (Vol. 56, No. ...
Read more : Opexa related info | Views : 1869 | Replies : 3


Loobie's 3rd update

Ok,

I'm ready to update again. I have really waited this time since I was pinging off of on so many false alarms. I have used the 4 day rule suggested by Tim (it's good advice when self monitoring) and have lots to talk about.

The amount of changes are huge to me. I'm either seeing some results or I have the biggest placebo effect ever encountered. As some of you know from my previous ...
Read more : Loobie's 3rd update | Views : 4475 | Replies : 19


 

Login  •  Register


Statistics

Total posts 227084 • Total topics 23944 • Total members 15257


Contact us | Terms of Service